Show simple item record

dc.contributor.authorGuzman-Vilca, W.C.
dc.contributor.authorQuispe-Villegas, G.A.
dc.contributor.authorVáscones Román, F.F.
dc.contributor.authorBernabe-Ortiz, A.
dc.contributor.authorCarrillo-Larco, R.M.
dc.date.accessioned2025-10-31T18:33:32Z
dc.date.available2025-10-31T18:33:32Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/20.500.12805/4962
dc.description.abstractObjective To determine the agreement between the cardiovascular disease (CVD) risk predictions computed with the WHO non-laboratory-based model and laboratory-based model in a nationally representative sample of Peruvian adults. Design Cross-sectional analysis of a national health survey. Methods Absolute CVD risk was computed with the 2019 WHO laboratory-based and non-laboratory-based models. The risk predictions from both models were compared with Bland-Altman plots, Lin's concordance coefficient correlation (LCCC), and kappa statistics, stratified by sex, age, body mass index categories, smoking and diabetes status. Results 663 people aged 30-59 years were included in the analysis. Overall, there were no substantial differences between the mean CVD risk computed with the laboratory-based model 2.0% (95% CI 1.8% to 2.2%) and the non-laboratory-based model 2.0% (95% CI 1.8% to 2.1%). In the Bland-Altman plots, the limits of agreement were the widest among people with diabetes (-0.21; 4.37) compared with people without diabetes (-1.17; 0.95). The lowest agreement as per the LCCC was also seen in people with diabetes (0.74 (95% CI 0.63 to 0.82)), the same was observed with the kappa statistic (kappa=0.36). In general, agreement between the scores was appropriate in terms of clinical significance. Conclusions The absolute cardiovascular predicted risk was similar between the laboratory-based and non-laboratory-based 2019 WHO cardiovascular risk models. Pending validation from longitudinal studies, the non-laboratory-based model (instead of the laboratory-based) could be used when assessing CVD risk in Peruvian population.en_US
dc.description.sponsorshipRMC-L is supported by a Wellcome Trust International Training Fellowship (214185/Z/18/Z).
dc.formatapplication/pdf
dc.language.isoeng
dc.publisherBMJ Publishing Group
dc.relation.ispartofurn:issn:2044-6055
dc.rightshttps://purl.org/coar/access_right/c_abf2
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectSDG 3en_US
dc.subjectHypertension Management and Dietary Sodium Impacten_US
dc.subjectCardiovascular Risk Assessment and Management Strategiesen_US
dc.titleAgreement between the laboratory-based and non-laboratory-based WHO cardiovascular risk charts: a cross-sectional analysis of a national health survey in Peruen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2022-063289
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.09
dc.type.otherResearch article
dc.identifier.journalBMJ Open
dc.type.versionhttps://purl.org/coar/version/c_970fb48d4fbd8a85


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

https://purl.org/coar/access_right/c_abf2
Except where otherwise noted, this item's license is described as https://purl.org/coar/access_right/c_abf2